Fibrolamellar Cancer Foundation Research Grant

About this program

The Fibrolamellar Cancer Foundation (FCF) funds innovative research to advance understanding, diagnosis, epidemiology, and development of curative therapies for fibrolamellar carcinoma (FLC), with priority for projects that have a clear path toward novel treatments or clinical trials. Applicants must be employed by an institution engaged in health-related research and propose projects focused specifically on FLC; collaboration and open sharing of data/resources are required, and the Foundation seeks to avoid funding redundant efforts or displacing existing support. FCF reviews applications three times annually (deadlines March 1, July 1, November 1) and is open to time-sensitive requests by prior agreement; funded grantees must provide semi-annual financial and scientific progress reports. For questions or to discuss proposal concepts, contact Payal Ray (pray@fibrofoundation.org) or Mark Furth (mfurth@fibrofoundation.org).